We are pleased to have published our 2025 Annual Report showing how we worked towards our strategic aims during the year. The report details many significant developments for our organisation which you can read more about here.
If your child is aged between 6 months and 4 years old, please be aware of a recent change with the syringe associated with Levetiracetam (Keppra) 150ml oral.
Following the publication of her first two books, Roisin has decided that a donation from the sales of her third novel will go towards supporting our work.
A study in University College Cork wants to explore how people disclose their diagnosis of a long-term health condition. Can you help with this research?
These are a few tips for people living with epilepsy and their families to remember during this warm and sunny weather.
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee recently decided to keep the precautionary safety measures associated with Sodium Valproate treatment in men. Read more about the measures here.
We are looking forward to working with colleagues in FutureNeuro on the EPI-SLEEP study, which will evaluate the use of sleep technology in adults with epilepsy.
If you or a loved one are taking the Anti Seizure Medication, Ontozry, please familiarise yourself with important new safety measures associated with the medication following the emergence of new data.
Good luck to the Leaving Cert class of 2026!
Epilepsy Ireland addresses Sodium Valproate inquiry
Want the latest epilepsy & Epilepsy Ireland news straight to your inbox?
Keep in touch and sign up for our monthly email update!